We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alkermes PLC | NASDAQ:ALKS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.19 | 0.80% | 24.05 | 22.69 | 25.69 | 24.48 | 23.92 | 24.14 | 1,347,148 | 01:00:00 |
From May 2019 to May 2024
Aripiprazole lauroxil, or Aristada, is a chemical entity that, once injected into the body, undergoes steps to yield aripiprazole, whose trade name is Abilify. Earlier versions of this article and an earlier correction mischaracterized the entity as being a generic version of Abilify itself and of yielding a generic version of Abilify, as well as referred to the entity by only part of its name.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
October 06, 2015 20:43 ET (00:43 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
1 Year Alkermes Chart |
1 Month Alkermes Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
